Clinical Trial Update: PM8002 in Combination With Chemotherapy as First Line Therapy in Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PM8002 in combination with chemotherapy as first-line therapy for hepatocellular carcinoma; the study is currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• PM8002

Snippet

Sponsor: Biotheus Inc. | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING